U.S. Markets closed

Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $790,000 of Shares

- By insider

CEO of Odonate Therapeutics Inc (ODT) Kevin C Tang bought 40,000 shares of ODT on 09/26/2018 at an average price of $19.75 a share. The total cost of this purchase was $790,000.

Odonate Therapeutics Inc is a pharmaceutical company which is engaged in the development of therapeutics which improves and extend the lives of patients with cancer. It is developing tesetaxel an chemotherapy agent used in the treatment of cancer. Odonate Therapeutics Inc has a market cap of $507.180 million; its shares were traded at around $18.86 .


CEO Recent Trades:

  • CEO, 10% Owner Kevin C Tang bought 40,000 shares of ODT stock on 09/26/2018 at the average price of $19.75. The price of the stock has decreased by 4.51% since.
  • CEO, 10% Owner Kevin C Tang bought 90,000 shares of ODT stock on 09/20/2018 at the average price of $19.55. The price of the stock has decreased by 3.53% since.

For the complete insider trading history of ODT, click here

.This article first appeared on GuruFocus.